{"title":"在 LVEF 保持不变的心肌梗死患者中,长期使用β-受体阻滞剂与不使用β-受体阻滞剂相比,并不能减少 3.5 年后的全因死亡或心肌梗死。","authors":"Belal Suleiman, Christopher B Granger","doi":"10.7326/ANNALS-24-01163-JC","DOIUrl":null,"url":null,"abstract":"<p><strong>Source citation: </strong>Yndigegn T, Lindahl B, Mars K, et al; REDUCE-AMI Investigators. <b>Beta-blockers after myocardial infarction and preserved ejection fraction.</b> N Engl J Med. 2024;390:1372-1381. 38587241.</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":null,"pages":null},"PeriodicalIF":19.6000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"In MI with preserved LVEF, long-term β-blocker use vs. no use did not reduce all-cause death or MI at 3.5 y.\",\"authors\":\"Belal Suleiman, Christopher B Granger\",\"doi\":\"10.7326/ANNALS-24-01163-JC\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Source citation: </strong>Yndigegn T, Lindahl B, Mars K, et al; REDUCE-AMI Investigators. <b>Beta-blockers after myocardial infarction and preserved ejection fraction.</b> N Engl J Med. 2024;390:1372-1381. 38587241.</p>\",\"PeriodicalId\":7932,\"journal\":{\"name\":\"Annals of Internal Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":19.6000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Internal Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.7326/ANNALS-24-01163-JC\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/8/6 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Internal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7326/ANNALS-24-01163-JC","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/6 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
来源引用:Yndigegn T, Lindahl B, Mars K, et al; REDUCE-AMI Investigators.心肌梗死后保留射血分数的β-受体阻滞剂。N Engl J Med.2024;390:1372-1381.38587241.
期刊介绍:
Established in 1927 by the American College of Physicians (ACP), Annals of Internal Medicine is the premier internal medicine journal. Annals of Internal Medicine’s mission is to promote excellence in medicine, enable physicians and other health care professionals to be well informed members of the medical community and society, advance standards in the conduct and reporting of medical research, and contribute to improving the health of people worldwide. To achieve this mission, the journal publishes a wide variety of original research, review articles, practice guidelines, and commentary relevant to clinical practice, health care delivery, public health, health care policy, medical education, ethics, and research methodology. In addition, the journal publishes personal narratives that convey the feeling and the art of medicine.